Search for: "Novo Nordisk A/S" Results 41 - 60 of 305
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Oct 2010, 9:59 pm by Patent Docs
Sun and Caraco counterclaimed that Novo's patent was... [read post]
6 Dec 2010, 2:45 am by Seth
Novo Nordisk is familiar to many as a National Public Radio sponsor but is familiar to Minneapolis-based Paddock Laboratories as a competitor in “pharmaceutical combinations” for the treatment of Type2 diabetes. [read post]
23 Mar 2015, 2:55 pm by Tom Lamb
In both AstraZeneca's Bydureon Prescribing Information and Novo Nordisk's Victoza Prescribing Information, the March 2015 label revisions concerning medullary thyroid carcinoma (MTC) can be seen in the so-called "Black Box" warning at the beginning of that document as well as at part 5.1 Risk of Thyroid C-cell Tumors in the Warnings and Precautions section. [read post]
3 Aug 2021, 12:28 pm by Mike Rappaport
Days after her latest video, Ozempic’s makers, Novo Nordisk, obtained approval from the Food and Drug Administration to sell a new, higher dose version of the drug called Wegovy—one explicitly meant to help people with obesity, long since (and more controversially as of late) defined as having a body mass index over 30, lose weight. [read post]
9 Sep 2013, 8:24 pm
 Category: 103    By: John Kirkpatrick, Contributor TitleNovo Nordisk A/S v. [read post]
26 Dec 2007, 6:07 am
THE HUCKABEE / NOVO NORDISK STEM CELL STORY doesn't seem to be getting much media traction. [read post]
29 Sep 2023, 6:13 am by Mary Anne Peck
Similar so-called GLP-1 agonist medications Wegovy, also made by Novo Nordisk, and Mounjaro, from Eli Lilly, already acknowledge such reports in their labeling. ( CBS NEWS ) MN Tops AARP’s Long-Term Care Scorecard Minnesota, Washington, the District of Columbia, Massachusetts and Colorado received top marks in AARP’s 2023 LTSS State Scorecard, which measures the performance of state long-term services and support systems. [read post]
12 Apr 2010, 6:23 am by Mark Zamora
Data on intravenous dosing and a once-weekly version of Byetta “seem to give a similar signal” as cancers seen in rodent studies of Novo Nordisk A/Ss competing Victoza, said Curtis Rosebraugh, head of the Food and Drug Administration’s Office of Drug Evaluation II, in a Jan. 25 memo posted on the agency’s Web site. [read post]
21 Oct 2009, 9:13 am by Dennis Crouch
[POPA][Washington Post] Novo Nordisk v. [read post]
2 Sep 2022, 11:15 am by Steve Brachmann
Patent and Trademark Office (USPTO) extends the public comment period on the agency’s subject matter eligibility guidance; Novo Nordisk improves its sickle cell and rare blood disease treatment portfolio with a $1.1 billion purchase of Forma Therapeutics; the Delhi High Court orders India’s messaging service Telegram to disclose the IP addresses of Telegram users engaging in copyright infringement; and the Federal Circuit rules that… [read post]
2 Sep 2022, 11:15 am by Steve Brachmann
Patent and Trademark Office (USPTO) extends the public comment period on the agency’s subject matter eligibility guidance; Novo Nordisk improves its sickle cell and rare blood disease treatment portfolio with a $1.1 billion purchase of Forma Therapeutics; the Delhi High Court orders India’s messaging service Telegram to disclose the IP addresses of Telegram users engaging in copyright infringement; and the Federal Circuit rules that… [read post]
6 Oct 2023, 10:45 am by Alec Pronk
Court of Appeals for the Federal Circuit (CAFC) issues two precedential patent opinions; X Social Media sues Elon Musk’s social media platform X for copyright infringement; and the PTAB grants Mylan Pharmaceutical’s petition for an inter partes review on the validity of Novo Nordisks Ozempic and Wegovy patents. [read post]
6 Oct 2023, 10:45 am by Alec Pronk
Court of Appeals for the Federal Circuit (CAFC) issues two precedential patent opinions; X Social Media sues Elon Musk’s social media platform X for copyright infringement; and the PTAB grants Mylan Pharmaceutical’s petition for an inter partes review on the validity of Novo Nordisks Ozempic and Wegovy patents. [read post]
17 Mar 2011, 11:28 am by Morse, Barnes-Brown Pendleton
Food and Drug Administration on the company’s V-Go Disposable Insulin Delivery Device for use with Novo Nordisks NovoLog® for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing [...] [read post]